NCT04065477

Brief Summary

This research aims to test aspects of a computer-based cognitive rehabilitation program designed to improve thinking skills in individuals with traumatic brain injury (TBI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 22, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

January 29, 2024

Status Verified

January 1, 2024

Enrollment Period

3.5 years

First QC Date

July 18, 2019

Last Update Submit

January 26, 2024

Conditions

Keywords

Traumatic Brain InjuryTBIBrain Injury

Outcome Measures

Primary Outcomes (3)

  • Intervention Tolerability Assessment Scale

    visual analog scale to assess participants' tolerability of intervention

    baseline through final follow-up assessment (16 weeks)

  • Recruitment rate percentage

    percentage of interested participants who met eligibility criteria via phone screen are eligible at in person screen

    phone screen to in-person screen (within 2 weeks)

  • Retention rate percentage

    adherence rate to treatment sessions within 8 weeks (i.e., attendance at 16 sessions), 12 weeks (24 sessions), and 16 weeks (32 sessions)

    baseline to mid-intervention assessment #2 (8 weeks), mid-intervention assessment #3 (12 weeks), and final follow-up (16 weeks)

Secondary Outcomes (2)

  • Changes in time monitoring & time-based prospective memory

    16 weeks

  • Changes in strategic cognitive functions (performance on NIH EXAMINER)

    16 weeks

Study Arms (2)

Experimental

EXPERIMENTAL

The experimental group will receive treatment program designed to train strategic cognitive functions. Sessions will last 50 minutes and take place twice per week for 16 weeks.

Behavioral: computer-based cognitive rehabilitation (CBCR)

Control group

NO INTERVENTION

The control group will receive no active treatment and will be treated as a "no-contact control" group.

Interventions

Program designed to improve strategic cognitive domains (e.g., complex attention, working memory)

Experimental

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sustained a moderate-to-severe TBI at least one year prior to assessment
  • Fluent in English
  • Demonstrate impairment in strategic cognitive abilities

You may not qualify if:

  • Significant neurological history other than TBI
  • Significant psychiatric history (e.g., bipolar disorder, schizophrenia)
  • Significant substance abuse history
  • Steroid and/or benzodiazepine use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

East Hanover, New Jersey, 07936, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticBrain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Erica Weber, PhD

    Kessler Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Study staff conducting baseline and follow-up assessments will be blind as to which group participants are placed. Study staff conducting intervention sessions will be blind to participants' baseline and follow-up assessment performance.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

July 18, 2019

First Posted

August 22, 2019

Study Start

October 1, 2019

Primary Completion

March 31, 2023

Study Completion

March 31, 2024

Last Updated

January 29, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations